Opportunity

SAM #RFQ-FDA-134493

FDA Weekly Dry Ice Supply and Delivery Services for Laboratory Operations

Buyer

FDA Office of the Associate General Counsel for Administrative Law

Posted

August 10, 2026

Respond By

August 21, 2026

Identifier

RFQ-FDA-134493

NAICS

325120, 424490, 312113

This opportunity is for the weekly supply and delivery of commercial-grade dry ice to support laboratory operations for the U.S. Food and Drug Administration (FDA), Human Foods Program (HFP), Office of Laboratory Operations and Applied Science (OLOAS). - Government Buyer: - U.S. Food and Drug Administration (FDA) - Human Foods Program (HFP) - Office of Laboratory Operations and Applied Science (OLOAS) - Products/Services Requested: - Commercial-grade dry ice in two forms: pellets and bagged blocks - Estimated 1,550 pounds per week (80,600 pounds annually) - Delivered to three FDA laboratory locations (MOD-1, Wiley Building, University Station) - Specific weekly quantities: - 770 lbs pellets (MOD-1) - 550 lbs pellets (Wiley Building) - 230 lbs bagged blocks (University Station) - Recurring weekly delivery service (52 weeks per year) - All personnel, supervision, management, materials, transportation, and equipment required for delivery - Unique/Notable Requirements: - Compliance with OSHA, DOT, and FDA facility security requirements - Timely delivery on Wednesdays during normal Federal business hours (or next business day if closed) - Accurate quantity delivery and proper documentation - Delivery must begin within 10 business days after award - Small business set-aside under NAICS code 325120 - Contract includes a 12-month base period with four 12-month option periods (potentially up to 5 years) - No specific OEMs or brands are named; commercial dry ice suppliers are eligible.

Description

The U.S. Food and Drug Administration (FDA), Human Foods Program (HFP), Office of Laboratory Operations and Applied Science (OLOAS), requires weekly delivery of dry ice to support laboratory testing, scientific research, regulatory activities, and other mission-critical laboratory operations across multiple HFP offices. See details of requirements in RFQ and Attachment 1 (PWS). ****************************************************************************** Amendment 0001:

The purpose of this amendment 0001 to RFQ is:

1. Amend RFQ by adding Section 4:

Section 4 Points of Contact

Contracting Officer (CO): Name: Sarah Hussain Email: sarah.hussain@fda.hhs.gov Phone: 301-796-3940  

2. Amend RFQ Section 7: Correct Questions Due: From: June 18, 2026 at 10 AM EST To:     August 12, 2026 at 3 PM EST

No further questions will be answered after the deadline. An amendment to the RFQ will be issued to provide the Government responses to the questions.

Except as amended herein, all terms and conditions of solicitation RFQ-FDA-134493 remain unchanged and in full force and effect. Secondary point of contact added Contract Specialist: Aarati Singal; Email: aarati.singal@fda.hhs.gov, please copy Contract Specialist (CS) and CO in any questions/offers submitted in response to this RFQ. 

View original listing